MUTATION OF TYR697, A GRB2-BINDING SITE, AND TYR721, A PI-3-KINASE BINDING-SITE, ABROGATES SIGNAL-TRANSDUCTION BY THE MURINE CSF-1 RECEPTOR EXPRESSED IN RAT-2 FIBROBLASTS

被引:141
作者
VANDERGEER, P
HUNTER, T
机构
[1] Molecular Biology and Virology Lab, The Salk Institute, San Diego, CA 92185-5800
关键词
COLONY STIMULATING FACTOR-I; SIGNAL TRANSDUCTION; TYROSINE KINASES;
D O I
10.1002/j.1460-2075.1993.tb06211.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The receptor for the myeloid cell growth factor colony stimulating factor 1 (CSF-1) is a protein tyrosine kinase that is closely related to the PDGF receptor. Ligand binding results in kinase activation and autophosphorylation. Three autophosphorylation sites, Tyr697, Tyr706 and Tyr721, have been mapped to the kinase insert domain. Deletion of the entire kinase insert domain completely abrogates signal transduction by the CSF-1 receptor expressed in Rat-2 fibroblasts. To investigate the function of individual phosphorylation sites present in the CSF-1 receptor kinase insert domain, a number of phosphorylation site mutants were expressed in Rat-2 fibroblasts. Mutation of either Tyr697 or Tyr721 compromised signal transduction by the CSF-1 receptor. A mutant receptor, in which both Tyr697 and Tyr721 were replaced by phenylalanine, has lost all ability to induce changes in morphology or to increase cell growth rate in response to CSF-1. Tyr721 has been identified recently as the binding site for PI 3-kinase. Here we report that GRB2 associates with the CSF-1 receptor upon ligand binding. The phosphorylation on tyrosine of SHC and several other GRB2-associated proteins increased upon stimulation with CSF-1. Tyr697 was identified as a binding site for GRB2. We suggest that PI 3-kinase, GRB2 and some of the GRB2-associated proteins could play an important role in signal transduction by the CSF-1 receptor.
引用
收藏
页码:5161 / 5172
页数:12
相关论文
共 83 条
[31]  
LUO K, 1990, ONCOGENE, V5, P921
[32]  
MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667
[33]   ISOLATION OF A NOVEL RECEPTOR CDNA ESTABLISHES THE EXISTENCE OF 2 PDGF RECEPTOR GENES [J].
MATSUI, T ;
HEIDARAN, M ;
MIKI, T ;
POPESCU, N ;
LAROCHELLE, W ;
KRAUS, M ;
PIERCE, J ;
AARONSON, S .
SCIENCE, 1989, 243 (4892) :800-804
[34]   A RECEPTOR TYROSINE KINASE SPECIFIC TO HEMATOPOIETIC STEM AND PROGENITOR CELL-ENRICHED POPULATIONS [J].
MATTHEWS, W ;
JORDAN, CT ;
WIEGAND, GW ;
PARDOLL, D ;
LEMISCHKA, IR .
CELL, 1991, 65 (07) :1143-1152
[35]   CLONING OF ASH, A UBIQUITOUS PROTEIN COMPOSED OF ONE SRC HOMOLOGY REGION (SH)-2 AND 2 SH3 DOMAINS, FROM HUMAN AND RAT CDNA LIBRARIES [J].
MATUOKA, K ;
SHIBATA, M ;
YAMAKAWA, A ;
TAKENAWA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) :9015-9019
[36]  
Mayer Bruce J., 1993, Trends in Cell Biology, V3, P8, DOI 10.1016/0962-8924(93)90194-6
[37]   SHC PROTEINS ARE PHOSPHORYLATED AND REGULATED BY THE V-SRC AND V-FPS PROTEIN-TYROSINE KINASES [J].
MCGLADE, J ;
CHENG, A ;
PELICCI, G ;
PELICCI, PG ;
PAWSON, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) :8869-8873
[38]   THE SH2/SH3 DOMAIN-CONTAINING PROTEIN NCK IS RECOGNIZED BY CERTAIN ANTI-PHOSPHOLIPASE C-GAMMA-1 MONOCLONAL-ANTIBODIES, AND ITS PHOSPHORYLATION ON TYROSINE IS STIMULATED BY PLATELET-DERIVED GROWTH-FACTOR AND EPIDERMAL GROWTH-FACTOR TREATMENT [J].
MEISENHELDER, J ;
HUNTER, T .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (12) :5843-5856
[39]   IDENTIFICATION OF 2 JUXTAMEMBRANE AUTOPHOSPHORYLATION SITES IN THE PDGF BETA-RECEPTOR - INVOLVEMENT IN THE INTERACTION WITH SRC FAMILY TYROSINE KINASES [J].
MORI, S ;
RONNSTRAND, L ;
YOKOTE, K ;
ENGSTROM, A ;
COURTNEIDGE, SA ;
CLAESSONWELSH, L ;
HELDIN, CH .
EMBO JOURNAL, 1993, 12 (06) :2257-2264
[40]   IRS-1 ACTIVATES PHOSPHATIDYLINOSITOL 3'-KINASE BY ASSOCIATING WITH SRC HOMOLOGY-2 DOMAINS OF P85 [J].
MYERS, MG ;
BACKER, JM ;
SUN, XJ ;
SHOELSON, S ;
HU, P ;
SCHLESSINGER, J ;
YOAKIM, M ;
SCHAFFHAUSEN, B ;
WHITE, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10350-10354